Insider filing
Traded Aug 18, 2025 · filed 144 days later
Not classified as an open-market trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 5, 2025 · Filed Dec 10, 2025
Jazz Pharmaceuticals's SVP, Chief Accounting Officer sold $770K of Jazz Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$770,405
Shares × reported transaction price
30 days after results of Nov 5, 2025, 38 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $169.70 on Dec 5, 2025, 74% above its 52-week low and 6% below its high, after a 23% rise over the previous 30 trading days
52-week range $97.78 (May 9, 2025) to $180.90 (Nov 24, 2025), 87% of the way up, from 250 adjusted closes. 30 trading days earlier: $138.18 on Oct 23, 2025. Describes the past only, not a forecast
RSI 62, 35% above its 200-day average, 16% above its 50-day average, 6% below the 52-week high, 20-day volatility 75% a year, against the S&P 500: +22 points over 1 month, +25 points over 3 months, +38 points over 6 months
From the adjusted closes up to Dec 5, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | 0.0% | −2.4% | +2.3% |
| 30 days | −2.3% | +0.9% | −3.3% |
| 90 days | +12.7% | −1.5% | +14.2% |
| 180 days | +40.7% | +7.5% | +33.1% |
Past results only. Not a forecast.
Insider filing
Traded Aug 18, 2025 · filed 144 days later
Not classified as an open-market trade.
Insider selling
Traded Dec 9, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
Jazz Pharmaceuticals's SVP, Technical Operations sold $379K of Jazz Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Dec 5, 2025 · filed 5 days later
Routine share withholding; mechanical by default.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: reported its results, 30 days earlier (Nov 5, 2025). The first one after it: reported its results, 38 days later (Jan 12, 2026).